BRAF mutations and KIT aberrations and their clinicopathological correlation in 202 Korean melanomas

Journal of Investigative Dermatology

Volumn 133, Issue 2, 2013, Pages 579-582

  Jin, Sun A ^a   Chun, Seung Min ^a   Choi, Yoo Duk ^a   Kweon, Sun Seog ^a   Jung, Sung Taek ^a   Shim, Hyun Jeong ^a   Yun, Sook Jung ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; PROTEIN; PROTEIN KIT; UNCLASSIFIED DRUG;

ADULT; CANCER PATIENT; COPY NUMBER VARIATION; DNA EXTRACTION; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL;

EID: 84872607087     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.338     Document Type: Letter

References (13)

1. Ashida A, Takata M, Murata H et al. (2009) Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas. Int J Cancer 124:862-8
2. Beadling C, Jacobson-Dunlop E, Hodi FS et al. (2008) KIT gene mutations in copy number in melanoma subtypes. Clin Cancer Res 14: 6821-8
3. Curtin JA, Busam K, Pinkel D et al. (2006) Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 24:4340-6
4. Curtin JA, Fridlyand J, Kageshita T et al. (2005) Distinct sets of genetic alterations in melanoma. N Eng J Med 353:2135-47
5. Davies H, Bignell GR, Cox C et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417:949-54
6. Ellerhorst JA, Greene VR, Ekmekcioglu S et al. (2011) Clinical correlates of NRAS and BRAF mutations in primary human melanoma. Clin Cancer Res 17:229-35
7. Kong Y, Si L, Zhu Y et al. (2011) Large-scale analysis of KIT aberrations in Chinese patients with melanoma. Clin Cancer Res 17:1684-91
8. Maleddu A, Pantaleo MA, Nannini M et al. (2011) The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting. J Transl Med 9:75
9. Qi RQ, He L, Zheng S et al. (2011) BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han. J Invest Dermatol 1311:1129-38
10. Si L, Kong Y, Xu X et al. (2012) Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort. Eur J Cancer 48:94-100
11. Terada T (2010) Low incidence of KIT gene mutations and no PDGFRA gene mutations in primary cutaneous melanoma: an immunohistochemical and molecular genetic study of Japanese cases. Int J Clin Oncol 15:453-6
12. Woodman SE, Davies MA (2010) Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics. Biochem Pharmacol 80:568-74
13. Yun J, Lee J, Jang J et al. (2011) KIT amplification and gene mutations in acral/mucosal melanoma in Korea. APMIS 119:330-5